12:00 AM
Aug 20, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AZD3241: Phase II started

In its 2Q12 earnings, AstraZeneca said that last quarter it began a double-blind, placebo-controlled Phase II trial...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >